Craft

Opsy

Stock Price

KR0.9

2024-10-29

Market Capitalization

KR7.7 M

2024-10-29

Revenue

KR6.7 M

FY, 2025

Opsy Summary

Company Summary

Overview
Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread. It offers anti-metastatic therapies that limit the ability of cancer cells to separate from the tumor and spread in the body to avoid metastasis.
Type
Public
Status
Active
Founded
2007
HQ
Gothenburg, SE | view all locations
Website
https://www.opsy.se/
Cybersecurity rating
Sectors

Key People

  • Jan Nilsson

    Jan Nilsson, Board Member

    • Tommy Andersson

      Tommy Andersson, Board Member

      • Klaus Christensen

        Klaus Christensen, CCO

        • Anders Tidfors

          Anders Tidfors, CFO

          Operating MetricsView all

          Patients

          65K

          FY, 2022

          LocationsView all

          2 locations detected

          • Gothenburg, Västra Götalands län HQ

            Sweden

            c/o The House, Björklundabacken 10

          • Lund, Skåne län

            Sweden

            c/o Er Redovisning, Stora Södergatan 15

          Opsy Financials

          Summary Financials

          Revenue (FY, 2025)
          kr6.7M
          Gross profit (FY, 2025)
          kr5.4M
          Net income (FY, 2025)
          (kr17.2M)
          Cash (FY, 2025)
          kr1.0M
          EBIT (FY, 2025)
          (kr17.1M)
          Enterprise value
          $7.9M

          Footer menu